Ghanaian Innovation Embraced by Indian Pharmaceutical Giants

*Themis Medicare, research-based Indian pharmaceutical industry leader,
announces a new agreement with multi-award winning mPedigree Network to
boost patient safety and drug quality using mPedigree's free text-messaging
technology backed by HP. The technology was pioneered in Ghana and is now
being deployed in a growing number of countries.*
**
The full release is here:

http://www.indiaprwire.com/pressrelease/medical/2011063090829.htm


*FOR IMMEDIATE RELEASE*

*Jun 29, 2011* – Themis Medicare, one of India’s leading research-based
healthcare companies, and a pioneer in pharmaceutical innovation in emerging
markets, has announced a new agreement with multiple award winning social
enterprise, mPedigree Network, which shall see consumers of Themis’
life-saving drugs verifying the authenticity and quality status of their
Themis’ brands for free via mobile phone text-messaging technology.
mPedigree Network which was first launched in Ghana in 2007 has quickly
grown to become one of the market-leading providers of electronic solutions
to the fake medicines problem in the African region, and now also in
South Asia.

The initial emphasis of the partnership is on Themis’ fast growing export
markets, with market-leading products, such as EMAL and Sepgard, benefitting
from this enhanced new product feature.

Themis Medicare thus joins an elite group of companies globally that have
deployed mPedigree’s best-in-class cloud computing platform, managed and
deployed by global technology leader Hewlett Packard, to protect and
reassure their customers about the quality and safety of their
pharmaceutical brands, using free text messages and unique scratch codes.

Dr. Dinesh Patel, CEO of Themis Medicare, remarked: “The philosophy of our
company is to break new ground in the provision of healthcare products at
the very cutting edge of therapeutic care. We recognize however that
increasing concerns about quality and safety requires that we must now go an
extra mile, in keeping with the same philosophy, to create a means for our
customers to be absolutely reassured that the medicine they are receiving
satisfies the high and uncompromising standards of quality we hold dear,
whatever the channel through which it was delivered, and that under no
circumstances could that promise of quality be compromised”.

Themis shall also draw on the extensive specialist knowledge and broad
expertise of mPedigree Network in further improving its electronic customer
satisfaction and supply chain visibility processes. Hundreds of millions of
South Asians and Africans now have access to mobile phones. This has
encouraged innovative companies like Themis to design new outreach services
best suited to needs of consumers in a digital age.


*About Themis Medicare*

Themis Medicare is a Mumbai-based, leading research-focused, pharmaceutical
company with four state-of-the-art manufacturing facilities at three
locations, in Vapi (Gujarat), Hyderabad (Andhra Pradesh), and Haridwar
(Uttarakhand). Themis is active in a growing number of therapeutic areas
like antituberculosis, antimalarials, cardiology, pain management,
anti-infectives, anesthesia, haematinics, Health & Nutrition, in addition to
an established presence in the active pharmaceutical ingredients space. The
company is also engaged in co-marketing its research based formulations with
other pharmaceutical companies in India and abroad. The 500 strong field
force of Themis Medicare, backed by a nationwide network of over 2000
stockists, ensures that the company's products are readily available across
India. This combined with the quality of the products means that Themis
Medicare is able to strengthen the hands of doctors by offering superior
treatment and healthcare solutions. It is Themis’ pledge to improve the
quality of life by enabling people to do more, feel better and live longer.
Themis Medicare has an expanding international portfolio of affiliates
across the globe with a presence in 40 countries. Additionally, the company
is planning to enter all 29 EU countries, USA, Canada, Australia with its
unique research formulations. A balanced geographical presence coupled with
a strong product flow from a wide therapeutic range serve as the core
strategic strength of the company. The official Themis Medicare website is:
http://www.themismedicare.com.


*About mPedigree Network

*mPedigree Networks partners 21 of the leading telecom companies in Africa
and Asia, leading pharmaceutical industry associations, and Fortune 100
technology powerhouses to empower African patients and consumers against the
fatal effects of pharmaceutical counterfeiting, which kills nearly a million
people a year, and maim countless more, in vulnerable parts of the world. As
a social enterprise, and a member of the Ashoka and World Economic Forum
communities, mPedigree maintains an equal obligation to consumer clients,
pharmaceutical clients, impact investors, and regulatory partners. mPedigree
has received the world’s most prestigious prizes for innovation, is endorsed
by intergovernmental organisations and is an accredited contractor to the
United States Federal Government. Additional information about mPedigree is
available at http://www.mpedigree.Net

For further information, Editors may contact:
Mr. Vikesh Tyagi
Themis Medicare Limited
11/12 Udyog Nagar, SV Road Goregaon (W), Mumbai - 400 104, India
Tel : 0091.22.67607080 Fax : 0091.22.67607070